• Mashup Score: 2

    At Friends of Cancer Research, we have long been committed to increasing efficiency in the development of new medicines through advancing groundbreaking science and innovative policy. The recent announcement that 3,500 FDA staff will be let go underscores just how serious and immediate the consequences of these cuts have become. Alongside broader reductions at NIH…

    Tweet Tweets with this article
    • Drastic cuts to the @US_FDA & @NIH workforce threaten to undermine scientific leadership and delay the treatments #patients are counting on. Smart investments not capricious cuts are what’s needed to stay at the forefront of innovation. Read our statement: https://t.co/mjTVrOhrrQ https://t.co/zp7me2Qa6x